Dr. Christina Nefeli Dimopoulos-Verma, MD

  • New Haven, CT
  • Gastroenterologist
NPI1053976738
Part D claims, 2024
35
Publications
1
Industry payments
$397
Insurance carriers
2
State licenses
2
Practice address
20 York St, New Haven, CT 06510
Practice phone
Call (650) 721-6190
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Dimopoulos-Verma's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Christina Nefeli Dimopoulos-Verma is a gastroenterologist in New Haven, Connecticut

Dr. Dimopoulos-Verma practices in New Haven, Connecticut.

Dr. Dimopoulos-Verma's NPI, 1053976738, was assigned on May 7, 2019. Dr. Dimopoulos-Verma graduated from Icahn School Of Medicine At Mount Sinai in 2019. Dr. Dimopoulos-Verma holds California license A185137.

NPI and contact details
NPI enumeration date
May 7, 2019
NPI status
Active
Practice phone
(650) 721-6190
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
33
Medical school graduation
2019

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Christina Nefeli Dimopoulos-Verma's practice address is in New Haven, Connecticut

Dr. Dimopoulos-Verma's practice address in the NPI Registry is 20 York St, New Haven, CT 06510, in South Central Ct County. The practice phone is (650) 721-6190.

  • NPI Registry address
    20 York St, New Haven, CT 06510 · South Central Ct CountyPhone(650) 721-6190

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Christina Nefeli Dimopoulos-Verma's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dimopoulos-Verma practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Dimopoulos-Verma's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Dimopoulos-Verma practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Christina Nefeli Dimopoulos-Verma is one of 298 gastroenterologists in Connecticut

Gastroenterology is Dr. Dimopoulos-Verma's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Dimopoulos-Verma is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Dimopoulos-Verma's licenses on file in 2 states: California and Connecticut.

Specialties and state licenses

  • Gastroenterology, CaliforniaPrimaryLicense A185137 · 2023 to 2027 · taxonomy 207RG0100X
  • Connecticut license2019 to 2023

Gastroenterologists near Dr. Dimopoulos-Verma

Counts of gastroenterologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Christina Nefeli Dimopoulos-Verma's patients have a median age of 66

Across all payers, Dmand AI patient panel data puts Dr. Dimopoulos-Verma's median patient age at 66, with 25% women.

Dr. Dimopoulos-Verma's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 66

Patient panel by sex, all payers

  • Women25%
  • Men75%

Source: Dmand AI Patient Panel Data

Dr. Christina Nefeli Dimopoulos-Verma wrote 35 Medicare Part D claims in 2024

In 2024, Dr. Dimopoulos-Verma wrote 35 Medicare Part D claims for 12 patients. 89% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $211 in total drug cost. In 2021, CMS named 52 claims across 2 drugs.

Part D claims, 202435
Drugs named by CMS2
Total drug cost$211
Part D patients12

Dr. Dimopoulos-Verma's Part D claims by kind of drug, 2024

  • Generic31 claims89%
  • Brand-name and other4 claims11%

Dr. Dimopoulos-Verma's most prescribed drugs by claims, 2022

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2021 to 2022

  • 2021
  • 2022
Claims for drugs CMS names
2021: 522022: 2650%

Drugs named by CMS: 2 in 2022, 2 in 2021.

See all prescribing by Dr. Dimopoulos-Verma

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find gastroenterologists like Dr. Dimopoulos-Verma by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Christina Nefeli Dimopoulos-Verma has 1 publication on record

Dmand AI links 1 paper to Dr. Dimopoulos-Verma in 2025. Dr. Dimopoulos-Verma's most frequent co-authors are Monique Theresa Barakat, MD, PhD, Grant Eric Barber, MD and David B. Bingham, MD.

Papers1

Dr. Dimopoulos-Verma's most frequent co-authors

Recent publications by Dr. Dimopoulos-Verma

See all 1 publications and co-authors

See who Dr. Dimopoulos-Verma researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Dimopoulos-Verma works with, so you can find a warm path to the right gastroenterologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Christina Nefeli Dimopoulos-Verma received $397 in industry payments from 2023 to 2025

CMS Open Payments shows 7 general payments to Dr. Dimopoulos-Verma from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $248.

General payments to Dr. Dimopoulos-Verma by program year, 2023 to 2025

Companies that paid Dr. Dimopoulos-Verma the most, 2023 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Dimopoulos-Verma

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Christina Nefeli Dimopoulos-Verma graduated from Icahn School Of Medicine At Mount Sinai

Dr. Dimopoulos-Verma graduated from Icahn School Of Medicine At Mount Sinai in 2019.

  1. Medical schoolIcahn School Of Medicine At Mount Sinai
  2. Board certified in internal medicineAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Christina Nefeli Dimopoulos-Verma accepts plans from 2 insurance carriers

Dr. Dimopoulos-Verma is in network with 2 carriers, including Blue Cross Blue Shield of Michigan and RI State Medicaid. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.

  • Blue Cross Blue Shield of Michigan
  • RI State Medicaid

Plan types Dr. Dimopoulos-Verma accepts, by number of carriers

  1. HMO1
  2. Medicaid1
  3. POS1
  4. PPO1

Source: Dmand AI Insurance Network Data

Sources for Dr. Christina Nefeli Dimopoulos-Verma's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Christina Nefeli Dimopoulos-Verma

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Christina Nefeli Dimopoulos-Verma's NPI number?

Dr. Christina Nefeli Dimopoulos-Verma's NPI number is 1053976738. It was assigned on May 7, 2019, and it is active in the NPI Registry.

What kind of doctor is Dr. Christina Nefeli Dimopoulos-Verma?

Dr. Christina Nefeli Dimopoulos-Verma is a gastroenterologist in New Haven, Connecticut. The primary specialty in the NPI Registry is Gastroenterology Physician (taxonomy code 207RG0100X).

Where does Dr. Christina Nefeli Dimopoulos-Verma practice?

Dr. Dimopoulos-Verma practices at 20 York St, New Haven, CT 06510.

What is Dr. Christina Nefeli Dimopoulos-Verma's office phone number?

The practice phone on file for Dr. Dimopoulos-Verma is (650) 721-6190.

What is Dr. Christina Nefeli Dimopoulos-Verma's medical license number?

Dr. Dimopoulos-Verma holds California license A185137, one of the licenses on file in 2 states.

Which states has Dr. Christina Nefeli Dimopoulos-Verma been licensed in?

Dmand AI has state licenses on file for Dr. Dimopoulos-Verma in California (2023 to 2027) and Connecticut (2019 to 2023).

Is Dr. Christina Nefeli Dimopoulos-Verma board certified?

Yes. Dr. Dimopoulos-Verma is board certified in internal medicine by the American Board of Internal Medicine.

Where did Dr. Christina Nefeli Dimopoulos-Verma go to medical school?

Dr. Dimopoulos-Verma graduated from Icahn School Of Medicine At Mount Sinai in 2019.

What drugs does Dr. Christina Nefeli Dimopoulos-Verma prescribe most?

In 2022 Medicare Part D data, Dr. Dimopoulos-Verma's most prescribed drugs by claims were Atorvastatin Calcium and Amlodipine Besylate.

Has Dr. Christina Nefeli Dimopoulos-Verma received payments from drug or device companies?

CMS Open Payments shows $397 in general payments to Dr. Dimopoulos-Verma from 2 companies from 2023 to 2025. The largest total came from Abbvie Inc.

Show 4 more questionsShow fewer questions

How long has Dr. Christina Nefeli Dimopoulos-Verma been practicing?

Dr. Dimopoulos-Verma graduated from medical school in 2019, 7 years ago.

Does Dr. Christina Nefeli Dimopoulos-Verma do research?

Dmand AI links 1 publication to Dr. Dimopoulos-Verma.

Who does Dr. Christina Nefeli Dimopoulos-Verma publish with?

Dr. Dimopoulos-Verma's most frequent co-authors are Monique Theresa Barakat, MD, PhD (1 shared paper), Grant Eric Barber, MD (1 shared paper) and David B. Bingham, MD (1 shared paper).

What insurance does Dr. Christina Nefeli Dimopoulos-Verma accept?

Dr. Dimopoulos-Verma is in network with 2 carriers, including Blue Cross Blue Shield of Michigan and RI State Medicaid. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.

Selling to gastroenterology practices?

See gastroenterologists in Connecticut by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)